CIK 0001721484
- Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472174146
- Phone
- +1 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 14 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-02 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Shares withheld for taxes | −5,123 | $1.32 | $7K | 42,443 |
| 2024-01-02 | Agafonova Nataliya Chief Medical Officer | Shares withheld for taxes | −3,074 | $1.32 | $4K | 20,786 |
| 2024-01-02 | Lehr Paul T General Counsel, Secretary | Shares withheld for taxes | −992 | $1.32 | $1K | 142,406 |
| 2023-12-29 | Baluch Khoso Director | Purchase | +8,322 | $1.43 | $12K | 15,000 |
| 2023-12-28 | Baluch Khoso Director | Purchase | +1,678 | $1.40 | $2K | 6,678 |
| 2023-12-28 | PFEFFER JEFFREY Director | Purchase | +10,000 | $1.35 | $14K | 15,000 |
| 2023-12-21 | Ross Cathy Director | Grant or award · Stock Option (Right to buy) | +12,000 | 12,000 | ||
| 2023-12-21 | LOSORDO DOUGLAS W Director | Grant or award · Stock Option (Right to buy) | +12,000 | 12,000 | ||
| 2023-12-21 | Hare Joshua Chief Scientific Officer | Grant or award · Stock Option (Right to buy) | +12,000 | 12,000 | ||
| 2023-12-21 | Soffer Rock Director | Grant or award · Stock Option (Right to buy) | +12,000 | 12,000 | ||
| 2023-12-21 | Ungaro Ursula Director | Grant or award · Stock Option (Right to buy) | +12,000 | 12,000 | ||
| 2023-12-21 | Hare Neil E Director | Grant or award · Stock Option (Right to buy) | +12,000 | 12,000 | ||
| 2023-12-21 | Baluch Khoso Director | Grant or award · Stock Option (Right to buy) | +12,000 | 12,000 | ||
| 2023-12-21 | PFEFFER JEFFREY Director | Grant or award · Stock Option (Right to buy) | +12,000 | 12,000 | ||
| 2023-10-02 | Lehr Paul T General Counsel, Secretary | Shares withheld for taxes | −815 | $2.29 | $2K | 143,398 |
| 2023-10-02 | Locklear Lisa Chief Financial Officer | Shares withheld for taxes | −4,078 | $2.29 | $9K | 40,922 |
| 2023-10-02 | Agafonova Nataliya Chief Medical Officer | Shares withheld for taxes | −3,059 | $2.29 | $7K | 23,860 |
| 2023-09-21 | Hare Joshua Chief Scientific Officer | Option exercise | +5,000 | $3.00 | $15K | 7,828,263 |
| 2023-09-21 | Hare Joshua Chief Scientific Officer | Option exercise · Subscription Rights (right to buy) | −5,000 | 39,191,771 | ||
| 2023-09-20 | Lehr Paul T General Counsel, Secretary | Option exercise | +2,000 | $3.00 | $6K | 144,213 |
Page 8 of 14 · 271 trades